CUSIP: 02318X100
Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,229,922
-
Share change
-
-57,000
-
Total reported value
-
$79,333,000
-
Price per share
-
$9.64
-
Number of holders
-
31
-
Value change
-
-$408,000
-
Number of sells
-
1
Quarterly Holders Quick Answers
What is CUSIP 02318X100?
CUSIP 02318X100 identifies AMBI - AMBIT BIOSCIENCES CORP - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2014
-
Previous quarter:
Q2 2013
Recent filing periods for CUSIP 02318X100:
Institutional Holders of AMBIT BIOSCIENCES CORP - COM (AMBI) as of Q4 2013
As of 31 Dec 2013,
AMBIT BIOSCIENCES CORP - COM (AMBI) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,229,922 shares.
The largest 10 holders included
Foresite Capital Management I, LLC, ORBIMED ADVISORS LLC, FMR LLC, BAKER BROS. ADVISORS LP, GREAT POINT PARTNERS LLC, Redmile Group, LLC, WEXFORD CAPITAL LP, Artal Group S.A., SPHERA FUNDS MANAGEMENT LTD., and BlackRock Institutional Trust Company, N.A..
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.